AstraZeneca PLC 2015 AR2
The report outlines AstraZeneca's strategic and financial progress in 2015, highlighting a 1% increase in Total Revenue to $24.7 billion at constant exchange rates, driven by an 11% growth in its key Growth Platforms. The company achieved significant pipeline milestones, including six regulatory approvals such as Tagrisso in the US and EU for lung cancer, and Zurampic for gout. AstraZeneca also expanded its biologics and cardiovascular portfolios through strategic acquisitions of ZS Pharma and a majority stake in Acerta Pharma. On the sustainability front, the company met its 2010-2015 target of reducing its operational carbon footprint by 21.2% and launched its new 2016-2025 Safety, Health, and Environment Strategy.
Company: AstraZeneca PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2015
Type: AR2
Pages: 256
Back to company
AstraZeneca PLC
Annual Report And Form 20-F Information
The report outlines AstraZeneca's strategic and financial progress in 2015, highlighting a 1% increase in Total Revenue to $24.7 billion at constant exchange rates, driven by an 11% growth in its key Growth Platforms. The company achieved significant pipeline milestones, including six regulatory approvals such as Tagrisso in the US and EU for lung cancer, and Zurampic for gout. AstraZeneca also expanded its biologics and cardiovascular portfolios through strategic acquisitions of ZS Pharma and a majority stake in Acerta Pharma. On the sustainability front, the company met its 2010-2015 target of reducing its operational carbon footprint by 21.2% and launched its new 2016-2025 Safety, Health, and Environment Strategy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees